Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Mutual detection of Kaposi's sarcoma-associated-Herpesvirus and Epstein Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma.

Labo N, Marshall V, Miley W, Davis E, McCann B, Stolka KB, Ndom P, Hemingway-Foday JJ, Abassora M, Newton R, Smith JS, Whitby D.

Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32546. [Epub ahead of print]

PMID:
31265124
2.

Relationship between human leukocyte antigen alleles and risk of Kaposi's sarcoma in Cameroon.

Cornejo Castro EM, Morrison BJ, Marshall VA, Labo N, Miley WJ, Clements N, Nelson G, Ndom P, Stolka K, Hemingway-Foday JJ, Abassora M, Gao X, Smith JS, Carrington M, Whitby D.

Genes Immun. 2019 May 20. doi: 10.1038/s41435-019-0077-9. [Epub ahead of print]

PMID:
31105266
3.

The contribution of KSHV to mortality in hospitalized HIV-infected patients being investigated for tuberculosis in South Africa.

Blumenthal MJ, Schutz C, Barr D, Locketz M, Marshall V, Whitby D, Katz AA, Uldrick T, Meintjes G, Schäfer G.

J Infect Dis. 2019 Apr 20. pii: jiz180. doi: 10.1093/infdis/jiz180. [Epub ahead of print]

PMID:
31004430
4.

A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma.

Ramaswami R, Uldrick TS, Polizzotto MN, Wyvill KM, Goncalves P, Widell A, Lurain K, Steinberg SM, Figg WD, Tosato G, Whitby D, Yarchoan R.

Clin Cancer Res. 2019 Jul 15;25(14):4238-4247. doi: 10.1158/1078-0432.CCR-18-3528. Epub 2019 Apr 12.

PMID:
30979736
5.

Viral, immunologic, and clinical features of primary effusion lymphoma.

Lurain K, Polizzotto MN, Aleman K, Bhutani M, Wyvill KM, Gonçalves PH, Ramaswami R, Marshall VA, Miley W, Steinberg SM, Little RF, Wilson W, Filie AC, Pittaluga S, Jaffe ES, Whitby D, Yarchoan R, Uldrick TS.

Blood. 2019 Apr 18;133(16):1753-1761. doi: 10.1182/blood-2019-01-893339. Epub 2019 Feb 19.

6.

Kaposi sarcoma.

Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D.

Nat Rev Dis Primers. 2019 Jan 31;5(1):9. doi: 10.1038/s41572-019-0060-9. Review.

PMID:
30705286
7.

Emergence of Kaposi's Sarcoma Herpesvirus-Associated Complications Following Corticosteroid Use in TB-IRIS.

Manion M, Uldrick T, Polizzotto MN, Sheikh V, Roby G, Lurain K, Metzger D, Mican JM, Pau A, Lisco A, Laidlaw E, Hammoud DA, Whitby D, Yarchoan R, Sereti I.

Open Forum Infect Dis. 2018 Oct 12;5(10):ofy217. doi: 10.1093/ofid/ofy217. eCollection 2018 Oct.

8.

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions.

Marshall VA, Labo N, Sztuba-Solinska J, Cornejo Castro EM, Aleman K, Wyvill KM, McNamara L, Le Grice SFJ, Yarchoan R, Uldrick TS, MacPhail P, Polizzotto MN, Whitby D.

Oncotarget. 2018 Nov 9;9(88):35856-35869. doi: 10.18632/oncotarget.26321. eCollection 2018 Nov 9.

9.

EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.

Blumenthal MJ, Schutz C, Meintjes G, Mohamed Z, Mendelson M, Ambler JM, Whitby D, Mackelprang RD, Carse S, Katz AA, Schäfer G.

Cancer Epidemiol. 2018 Oct;56:133-139. doi: 10.1016/j.canep.2018.08.005. Epub 2018 Aug 31.

10.

Epstein-Barr virus load is higher in long-term Hodgkin lymphoma survivors compared to their unaffected twins and unrelated controls.

Hwang AE, Marshall V, Conti DV, Nathwani BN, Mack TM, Whitby D, Cozen W.

Br J Haematol. 2019 Apr;185(2):377-380. doi: 10.1111/bjh.15522. Epub 2018 Aug 16. No abstract available.

PMID:
30117152
11.

Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands.

Miller JT, Zhao H, Masaoka T, Varnado B, Cornejo Castro EM, Marshall VA, Kouhestani K, Lynn AY, Aron KE, Xia A, Beutler JA, Hirsch DR, Tang L, Whitby D, Murelli RP, Le Grice SFJ.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00233-18. doi: 10.1128/AAC.00233-18. Print 2018 Oct.

12.

Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination.

Sallah N, Palser AL, Watson SJ, Labo N, Asiki G, Marshall V, Newton R, Whitby D, Kellam P, Barroso I.

J Infect Dis. 2018 Oct 20;218(11):1700-1710. doi: 10.1093/infdis/jiy427.

13.

Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV.

Marshall VA, Labo N, Hao XP, Holdridge B, Thompson M, Miley W, Brands C, Coalter V, Kiser R, Anver M, Golubeva Y, Warner A, Jaffe ES, Piatak M Jr, Wong SW, Ohlen C, MacAllister R, Smedley J, Deleage C, Del Prete GQ, Lifson JD, Estes JD, Whitby D.

PLoS Pathog. 2018 Jul 12;14(7):e1007130. doi: 10.1371/journal.ppat.1007130. eCollection 2018 Jul.

14.

Whole-genome association study of antibody response to Epstein-Barr virus in an African population: a pilot.

Sallah N, Carstensen T, Wakeham K, Bagni R, Labo N, Pollard MO, Gurdasani D, Ekoru K, Pomilla C, Young EH, Fatumo S, Asiki G, Kamali A, Sandhu M, Kellam P, Whitby D, Barroso I, Newton R.

Glob Health Epidemiol Genom. 2017 Nov 27;2:e18. doi: 10.1017/gheg.2017.16. eCollection 2017.

15.

Erratum to "Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda" [Cancer Epidemiol. 52 (2018) 70-74].

Ravell J, Otim I, Nabalende H, Legason ID, Reynolds SJ, Ogwang MD, Ndugwa CM, Marshall V, Whitby D, Goedert JJ, Engels EA, Bhatia K, Lenardo MJ, Mbulaiteye SM.

Cancer Epidemiol. 2018 Aug;55:192. doi: 10.1016/j.canep.2018.05.010. Epub 2018 Jun 1. No abstract available.

PMID:
29861403
16.

Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers.

Newton R, Labo N, Wakeham K, Marshall V, Roshan R, Nalwoga A, Sebina I, Muhangi L, Webb EL, Miley W, Rochford R, Elliott AM, Whitby D.

J Infect Dis. 2018 Aug 14;218(6):892-900. doi: 10.1093/infdis/jiy262.

17.

Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development.

Dai L, Del Valle L, Miley W, Whitby D, Ochoa AC, Flemington EK, Qin Z.

Oncogene. 2018 Aug;37(33):4534-4545. doi: 10.1038/s41388-018-0282-4. Epub 2018 May 10.

18.

Relationship Between Anemia, Malaria Coinfection, and Kaposi Sarcoma-Associated Herpesvirus Seropositivity in a Population-Based Study in Rural Uganda.

Nalwoga A, Cose S, Nash S, Miley W, Asiki G, Kusemererwa S, Yarchoan R, Labo N, Whitby D, Newton R.

J Infect Dis. 2018 Aug 24;218(7):1061-1065. doi: 10.1093/infdis/jiy274.

PMID:
29741631
19.

Age of Infection with Kaposi Sarcoma-Associated Herpesvirus and Subsequent Antibody Values Among Children in Uganda.

Nalwoga A, Miley W, Labo N, Elliott A, Cose S, Whitby D, Newton R.

Pediatr Infect Dis J. 2018 Aug;37(8):e225-e228. doi: 10.1097/INF.0000000000001909.

PMID:
29369149
20.

T-cell responses to KSHV infection: a systematic approach.

Roshan R, Labo N, Trivett M, Miley W, Marshall V, Coren L, Cornejo Castro EM, Perez H, Holdridge B, Davis E, Matus-Nicodemos R, Ayala VI, Sowder R 2nd, Wyvill KM, Aleman K, Fennessey C, Lifson J, Polizzotto MN, Douek D, Keele B, Uldrick TS, Yarchoan R, Ohlen C, Ott D, Whitby D.

Oncotarget. 2017 Nov 25;8(65):109402-109416. doi: 10.18632/oncotarget.22683. eCollection 2017 Dec 12.

21.

Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda.

Ravell J, Otim I, Nabalende H, Legason ID, Reynolds SJ, Ogwang MD, Ndugwa CM, Marshall V, Whitby D, Goedert JJ, Engels EA, Bhatia K, Lenardo MJ, Mbulaiteye SM.

Cancer Epidemiol. 2018 Feb;52:70-74. doi: 10.1016/j.canep.2017.12.004. Epub 2017 Dec 14. Erratum in: Cancer Epidemiol. 2018 Aug;55:192.

22.

Kaposi Sarcoma-Associated Herpesvirus in a Rural Ugandan Cohort, 1992-2008.

Newton R, Labo N, Wakeham K, Miley W, Asiki G, Johnston WT, Whitby D.

J Infect Dis. 2018 Jan 4;217(2):263-269. doi: 10.1093/infdis/jix569.

23.

Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA: a structural scaffold for nuclear, cytoplasmic and viral proteins.

Sztuba-Solinska J, Rausch JW, Smith R, Miller JT, Whitby D, Le Grice SFJ.

Nucleic Acids Res. 2017 Jun 20;45(11):6805-6821. doi: 10.1093/nar/gkx241.

24.

Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas.

Sanchez-Martin D, Uldrick TS, Kwak H, Ohnuki H, Polizzotto MN, Annunziata CM, Raffeld M, Wyvill KM, Aleman K, Wang V, Marshall VA, Whitby D, Yarchoan R, Tosato G.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx016.

25.

A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.

Uldrick TS, Gonçalves PH, Wyvill KM, Peer CJ, Bernstein W, Aleman K, Polizzotto MN, Venzon D, Steinberg SM, Marshall V, Whitby D, Little RF, Wright JJ, Rudek MA, Figg WD, Yarchoan R.

Oncologist. 2017 May;22(5):505-e49. doi: 10.1634/theoncologist.2016-0486. Epub 2017 Mar 24.

26.

A Scandcleft randomised trials of primary surgery for unilateral cleft lip and palate: 1. Planning and management.

Semb G, Enemark H, Friede H, Paulin G, Lilja J, Rautio J, Andersen M, Åbyholm F, Lohmander A, Shaw W, Mølsted K, Heliövaara A, Bolund S, Hukki J, Vindenes H, Davenport P, Arctander K, Larson O, Berggren A, Whitby D, Leonard A, Neovius E, Elander A, Willadsen E, Bannister RP, Bradbury E, Henningsson G, Persson C, Eyres P, Emborg B, Kisling-Møller M, Küseler A, Granhof Black B, Schöps A, Bau A, Boers M, Andersen HS, Jeppesen K, Marxen D, Paaso M, Hölttä E, Alaluusua S, Turunen L, Humerinta K, Elfving-Little U, Tørdal IB, Kjøll L, Aukner R, Hide Ø, Feragen KB, Rønning E, Skaare P, Brinck E, Semmingsen AM, Lindberg N, Bowden M, Davies J, Mooney J, Bellardie H, Schofield N, Nyberg J, Lundberg M, Karsten AL, Larson M, Holmefjord A, Reisæter S, Pedersen NH, Rasmussen T, Tindlund R, Sæle P, Blomhoff R, Jacobsen G, Havstam C, Rizell S, Enocson L, Hagberg C, Najar Chalien M, Paganini A, Lundeborg I, Marcusson A, Mjönes AB, Gustavsson A, Hayden C, McAleer E, Slevan E, Gregg T, Worthington H.

J Plast Surg Hand Surg. 2017 Feb;51(1):2-13. doi: 10.1080/2000656X.2016.1263202. Review.

PMID:
28218559
27.

Scandcleft randomised trials of primary surgery for unilateral cleft lip and palate: 2. Surgical results.

Rautio J, Andersen M, Bolund S, Hukki J, Vindenes H, Davenport P, Arctander K, Larson O, Berggren A, Åbyholm F, Whitby D, Leonard A, Lilja J, Neovius E, Elander A, Heliövaara A, Eyres P, Semb G.

J Plast Surg Hand Surg. 2017 Feb;51(1):14-20. doi: 10.1080/2000656X.2016.1254646. Review.

PMID:
28218552
28.

Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Peer CJ, Bevans M, Sereti I, Maldarelli F, Whitby D, Marshall V, Goncalves PH, Khetani V, Figg WD, Steinberg SM, Zeldis JB, Yarchoan R.

J Clin Oncol. 2016 Dec;34(34):4125-4131. Epub 2016 Oct 31.

29.

Beral et al's 1990 paper on Kaposi's sarcoma among persons with AIDS: demonstrating the power of descriptive epidemiology.

Newton R, Whitby D.

Cancer Epidemiol. 2016 Oct;44:222-225. doi: 10.1016/j.canep.2016.07.014. Epub 2016 Aug 21. Review.

PMID:
27554680
30.

Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).

Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, Whitby D, Pittaluga S, Jaffe ES, Millo C, Tosato G, Little RF, Steinberg SM, Sereti I, Yarchoan R.

Clin Infect Dis. 2016 Mar 15;62(6):730-738. doi: 10.1093/cid/civ996. Epub 2015 Dec 12.

31.

ORF33 and ORF38 of Kaposi's Sarcoma-Associated Herpesvirus Interact and Are Required for Optimal Production of Infectious Progeny Viruses.

Wu JJ, Avey D, Li W, Gillen J, Fu B, Miley W, Whitby D, Zhu F.

J Virol. 2015 Dec 4;90(4):1741-56. doi: 10.1128/JVI.02738-15. Print 2016 Feb 15.

32.

Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.

Choi HS, Jain V, Krueger B, Marshall V, Kim CH, Shisler JL, Whitby D, Renne R.

PLoS Pathog. 2015 Nov 6;11(11):e1005255. doi: 10.1371/journal.ppat.1005255. eCollection 2015.

33.

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma.

Dai L, Trillo-Tinoco J, Cao Y, Bonstaff K, Doyle L, Del Valle L, Whitby D, Parsons C, Reiss K, Zabaleta J, Qin Z.

Blood. 2015 Dec 24;126(26):2821-31. doi: 10.1182/blood-2015-07-658823. Epub 2015 Nov 3.

34.

Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein.

Wu JJ, Li W, Shao Y, Avey D, Fu B, Gillen J, Hand T, Ma S, Liu X, Miley W, Konrad A, Neipel F, Stürzl M, Whitby D, Li H, Zhu F.

Cell Host Microbe. 2015 Sep 9;18(3):333-44. doi: 10.1016/j.chom.2015.07.015. Epub 2015 Aug 27.

35.

Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study.

Goedert JJ, Martin MP, Vitale F, Lauria C, Whitby D, Qi Y, Gao X, Carrington M.

J Infect Dis. 2016 Feb 1;213(3):432-8. doi: 10.1093/infdis/jiv413. Epub 2015 Aug 12.

36.

Hepatitis C virus seroprevalence in the general female population from 8 countries.

Quesada P, Whitby D, Benavente Y, Miley W, Labo N, Chichareon S, Trong N, Shin HR, Anh PT, Thomas J, Matos E, Herrero R, Muñoz N, Molano M, Franceschi S, de Sanjosé S.

J Clin Virol. 2015 Jul;68:89-93. doi: 10.1016/j.jcv.2015.05.005. Epub 2015 May 12.

37.

Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.

Labo N, Miley W, Benson CA, Campbell TB, Whitby D.

AIDS. 2015 Jun 19;29(10):1217-25. doi: 10.1097/QAD.0000000000000682.

PMID:
26035321
38.

Serodiagnosis for tumor viruses.

Morrison BJ, Labo N, Miley WJ, Whitby D.

Semin Oncol. 2015 Apr;42(2):191-206. doi: 10.1053/j.seminoncol.2014.12.024. Epub 2014 Dec 31. Review.

39.

18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.

Polizzotto MN, Millo C, Uldrick TS, Aleman K, Whatley M, Wyvill KM, O'Mahony D, Marshall V, Whitby D, Maass-Moreno R, Steinberg SM, Little RF, Yarchoan R.

J Infect Dis. 2015 Oct 15;212(8):1250-60. doi: 10.1093/infdis/jiv204. Epub 2015 Mar 31.

40.

Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda.

Nalwoga A, Cose S, Wakeham K, Miley W, Ndibazza J, Drakeley C, Elliott A, Whitby D, Newton R.

Trop Med Int Health. 2015 May;20(5):665-672. doi: 10.1111/tmi.12464. Epub 2015 Feb 9.

41.

Agnathia-otocephaly complex and asymmetric velopharyngeal insufficiency due to an in-frame duplication in OTX2.

Sergouniotis PI, Urquhart JE, Williams SG, Bhaskar SS, Black GC, Lovell SC, Whitby DJ, Newman WG, Clayton-Smith J.

J Hum Genet. 2015 Apr;60(4):199-202. doi: 10.1038/jhg.2014.122. Epub 2015 Jan 15.

PMID:
25589041
42.

Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.

Wakeham K, Johnston WT, Nalwoga A, Webb EL, Mayanja BN, Miley W, Elliott AM, Whitby D, Newton R.

Int J Cancer. 2015 Jun 15;136(12):2822-30. doi: 10.1002/ijc.29329. Epub 2014 Nov 28.

43.

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Uldrick TS, Polizzotto MN, Aleman K, Wyvill KM, Marshall V, Whitby D, Wang V, Pittaluga S, O'Mahony D, Steinberg SM, Little RF, Yarchoan R.

Blood. 2014 Dec 4;124(24):3544-52. doi: 10.1182/blood-2014-07-586800. Epub 2014 Oct 20.

44.

Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome.

Labo N, Miley W, Marshall V, Gillette W, Esposito D, Bess M, Turano A, Uldrick T, Polizzotto MN, Wyvill KM, Bagni R, Yarchoan R, Whitby D.

PLoS Pathog. 2014 Mar 27;10(3):e1004046. doi: 10.1371/journal.ppat.1004046. eCollection 2014 Mar.

45.

Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon.

Stolka K, Ndom P, Hemingway-Foday J, Iriondo-Perez J, Miley W, Labo N, Stella J, Abassora M, Woelk G, Ryder R, Whitby D, Smith JS.

Cancer Epidemiol. 2014 Apr;38(2):137-43. doi: 10.1016/j.canep.2014.02.006. Epub 2014 Mar 13.

46.

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V, Pittaluga S, O'Mahony D, Whitby D, Tosato G, Steinberg SM, Little RF, Yarchoan R.

Blood. 2013 Dec 19;122(26):4189-98. doi: 10.1182/blood-2013-08-519959. Epub 2013 Oct 30.

47.

A Unique Case of Classic Kaposi's sarcoma restricted to the toes.

Renteria AS, Marshall VA, Sun Y, Chockalingam P, Cooper JS, Huang Y, Whitby D.

J Dermatol Case Rep. 2013 Sep 30;7(3):97-100. doi: 10.3315/jdcr.2013.1146. eCollection 2013.

48.

Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity.

Han SJ, Marshall V, Barsov E, Quiñones O, Ray A, Labo N, Trivett M, Ott D, Renne R, Whitby D.

J Virol. 2013 Nov;87(22):12237-48. doi: 10.1128/JVI.01202-13. Epub 2013 Sep 4.

49.

Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults.

Maskew M, MacPhail AP, Whitby D, Egger M, Fox MP.

J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):442-8. doi: 10.1097/QAI.0b013e3182969cc1.

50.

Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Venkataraman G, Uldrick TS, Aleman K, O'Mahony D, Karcher DS, Steinberg SM, Raffeld MA, Marshall V, Whitby D, Little RF, Yarchoan R, Pittaluga S, Maric I.

Am J Clin Pathol. 2013 May;139(5):651-61. doi: 10.1309/AJCPKGF7U8AWQBVG.

PMID:
23596117

Supplemental Content

Loading ...
Support Center